Literature DB >> 21666212

Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.

Carole J Hickman1, Terri B Hyde, Sun Bae Sowers, Sara Mercader, Marcia McGrew, Nobia J Williams, Judy A Beeler, Susette Audet, Bryan Kiehl, Robin Nandy, Azaibi Tamin, William J Bellini.   

Abstract

Waning immunity or secondary vaccine failure (SVF) has been anticipated by some as a challenge to global measles elimination efforts. Although such cases are infrequent, measles virus (MeV) infection can occur in vaccinated individuals following intense and/or prolonged exposure to an infected individual and may present as a modified illness that is unrecognizable as measles outside of the context of a measles outbreak. The immunoglobulin M response in previously vaccinated individuals may be nominal or fleeting, and viral replication may be limited. As global elimination proceeds, additional methods for confirming modified measles cases may be needed to understand whether SVF cases contribute to continued measles virus (MeV) transmission. In this report, we describe clinical symptoms and laboratory results for unvaccinated individuals with acute measles and individuals with SVF identified during MeV outbreaks. SVF cases were characterized by the serological parameters of high-avidity antibodies and distinctively high levels of neutralizing antibody. These parameters may represent useful biomarkers for classification of SVF cases that previously could not be confirmed as such using routine laboratory diagnostic techniques. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666212     DOI: 10.1093/infdis/jir106

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Outbreak of measles among persons with secondary vaccine failure, China, 2018.

Authors:  Zhujiazi Zhang; Meng Chen; Rui Ma; Jingbin Pan; Luodan Suo; Li Lu
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

2.  GUIDELINES FOR THE PREVENTION AND CONTROL OF MEASLES OUTBREAKS IN CANADA: An Advisory Committee Statement (ACS) Measles and Rubella Elimination Working Group (MREWG).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2013-10-30

3.  Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.

Authors:  Sara Mercader; Philip Garcia; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

4.  Control of a nosocomial measles outbreak among previously vaccinated adults in a population with high vaccine coverage: Korea, 2019.

Authors:  Kyunghyun Song; Ju Mi Lee; Eun Ju Lee; Bo Ram Lee; Ji Young Choi; Jihee Yun; Se Na Lee; Mi Young Jang; Han Wool Kim; Han-Sung Kim; Song Mi Moon; Yong Kyun Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-09       Impact factor: 3.267

Review 5.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

6.  Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.

Authors:  Amy Parker Fiebelkorn; Laura A Coleman; Edward A Belongia; Sandra K Freeman; Daphne York; Daoling Bi; Ashwin Kulkarni; Susette Audet; Sara Mercader; Marcia McGrew; Carole J Hickman; William J Bellini; Rupak Shivakoti; Diane E Griffin; Judith Beeler
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

7.  Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes.

Authors:  Núria Torner; Andres Anton; Irene Barrabeig; Sara Lafuente; Ignasi Parron; César Arias; Neus Camps; Josep Costa; Ana Martínez; Roser Torra; Pere Godoy; Sofia Minguell; Glòria Ferrús; Carmen Cabezas; Ángela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

8.  Asthma status and waning of measles antibody concentrations after measles immunization.

Authors:  Kwang Ha Yoo; Robert M Jacobson; Gregory A Poland; Amy Weaver; Linda Lee; Titus Chang; Young J Juhn
Journal:  Pediatr Infect Dis J       Date:  2014-10       Impact factor: 2.129

9.  Qualitative Variation among Commercial Immunoassays for Detection of Measles-Specific IgG.

Authors:  Donald R Latner; Sun B Sowers; Kiana Anthony; Heather Colley; Christine Badeau; Jessica Coates; Phili Wong; Yetunde Fakile; Cristina Interiano; Kevin B Pannell; Van Leung-Pineda; Manisha M Patel; Paul A Rota; Brandi M Limbago; Carole J Hickman
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

Review 10.  Current perspectives in assessing humoral immunity after measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-12-26       Impact factor: 5.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.